Ticker

MRNA

3 reports from NewsNTech on MRNA, newest first.

• Merck and Moderna report 42% reduction in melanoma death or recurrence

  RegulatoryOct 23, 2026

• Merck and Moderna's melanoma vaccine posts first positive Phase 3 for a personalized mRNA cancer therapy

  RegulatoryAug 20, 2026

• Quant funds rocked as Treasury buyback expansion and Moderna rally compound momentum stress

  TechAug 20, 2026